AEGiS-APPJ: U.S. Pregant Women's Perceptions of Universal, Routine Prenatal HIV Testing AIDS & Public Policy JournalImportant note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow
Print this Article


U.S. Pregant Women's Perceptions of Universal, Routine Prenatal HIV Testing

AIDS & Public Policy Journal 18, no. 3/4 (Fall/Winter 2003) 82-96
Sohini Sengupta and Bernard Lo


OBJECTIVE: This study explored U.S. pregnant women's perceptions of universal, routine prenatal HIV testing, a health policy change recommended by the Institute of Medicine (IOM) in 1999. The policy would eliminate offering an HIV test, separate informed consent, and pre-test counseling.

METHODS: We conducted 73 in-person interviews with African-American and Hispanic pregnant women at prenatal clinics in San Francisco, Washington, D.C., and Chapel Hill, N.C. The interview instrument elicited experiences about current prenatal HIV testing procedures and opinions about routine prenatal HIV testing. Interviews were audiotaped, transcribed, and read for content analysis and themes.

RESULTS: Under current prenatal HIV testing procedures, only 58 percent of the participants were asked by their careprovider if they wanted to be tested, and 49 percent were given pre-test counseling. When asked about their opinions on routine prenatal HIV testing, 63 percent liked it overall because more pregnant women would be tested, but 66 percent were concerned because pre-test counseling was not required. Almost 50 percent wanted pregnant women to be told explicitly that they were being tested for HIV.

CONCLUSION: In conclusion, these study findings will be useful to understand the importance of continuing to educate women about HIV and pregnancy in clinics that are moving toward the implementation of routine prenatal HIV testing as their standard of care.
030915
APPJ031803-03


Copyright © 2003 - AIDS & Public PolicyJournal. Reproduction of this article (other than one copy for personal reference) must be cleared through the APPJ Permissions Desk.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1986, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .